EAACI Congress 2024
https://www.globenewswire.com/NewsRoom/AttachmentNg/d32f0dd2-5510-4922-aead-62719b31e294
VALENCIA, Spain, March 19, 2024 (GLOBE NEWSWIRE) — The European Academy of Allergy and Clinical Immunology (EAACI), with a membership of over 16,000 from 125 countries, annually orchestrates its congress to unveil the latest research and innovative advancements in allergy and clinical immunology. We are thrilled to extend a warm invitation to you for the upcoming EAACI Congress 2024, scheduled to take place in Valencia from May 31st to June 3rd, 2024.
In a bid to provide you with an immersive experience, we will offer you a dedicated press area where you can schedule interviews with leading physicians and researchers in the field.
LOCATION:
Our venue, Feria de Valencia, is a prestigious convention and exhibition centre known for its modernity and versatility. Moreover, the event will take place at the vibrant city of Valencia, which is celebrated for its harmonious coexistence of tradition and modernity.
PROGRAMME:
The Scientific Programme will encompass the entire spectrum of Allergy and Clinical Immunology. Under the overarching theme of “Revolutionizing Patient Care Through the Power of Data Science” our congress promises to be an extraordinary intellectual journey. We are delighted to present a diverse and dynamic program featuring over 150 scientific sessions meticulously crafted to inform and inspire.
CONGRESS TOPICS:
KOLs of EAACI
In this link, you’ll find our dedicated committee, comprised of renowned doctors and scientists from various nationalities, available for interviews and reports.
PRESS RELEASE: https://eaaci.org/news/
SOCIAL MEDIA:
Podcast: https://linktr.ee/eaaci
LinkedIn: https://www.linkedin.com/company/eaaci/
Instagram: @eaaciHQ
Twitter: @EAACI_HQ
Facebook: https://www.facebook.com/EAACI
CONTACT: communications@eaaci.org
HASHTAGS: #EAACIannualCongress
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…
New leadership roles highlight Hallmark’s unique vendor-neutral approach to helping health systems build flexible, efficient,…
Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery SAN FRANCISCO and BERLIN, Dec. 23, 2024…
SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ -- Medit has launched a mobile app, MEDIT…